BASEL, Switzerland, Aug. 12 -- Liver Cancer, a peer-reviewed journal that says it focuses on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy of the disease, published research articles on the following topics in its August 2024 edition (Vol. 13, Issue 4):

Systematic Review:

* Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: . . .

Click here for more information about our products